FTC warns pharma companies about sham patent listings designed to delay generics
Hacker News
SEPTEMBER 18, 2023
For many, many years we’ve detailed how big pharma companies, who only care about the monopoly rents they can receive on medicine while under patent, have concocted all sorts of scams and schemes to avoid having to compete with generic versions, even after their patents have expired (or been invalidated).
Let's personalize your content